IMMUNOMODULATING AGENT, CELL ADHESION INHIBITOR AND AGENT FOR TREATMENT AND PREVENTION OF AUTOIMMUNE DISEASE
PROBLEM TO BE SOLVED: To provide an immunomodulating agent, a cell adhesion inhibitor and an agent for the treatment and prevention of autoimmune diseases except for rheumatoid arthritis. SOLUTION: A 4H-1-benzopyran-4-one derivative of formula or its salt has excellent immunomodulating action and ce...
Saved in:
Main Authors | , , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
27.05.2003
|
Edition | 7 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | PROBLEM TO BE SOLVED: To provide an immunomodulating agent, a cell adhesion inhibitor and an agent for the treatment and prevention of autoimmune diseases except for rheumatoid arthritis. SOLUTION: A 4H-1-benzopyran-4-one derivative of formula or its salt has excellent immunomodulating action and cell adhesion inhibiting action and is expectable to have an ameliorating effect on the autoimmune diseases except for rheumatoid arthritis comparable to the effect of steroid drugs. Accordingly, the 4H-1-benzopyran-4-one derivative of formula or its salt is useful for the treatment and prevention of autoimmune diseases except for rheumatoid arthritis (such as systemic lupus erythematosus, scleroderma, mixed connective tissue disease, polyarteritis nodosa, multiple myositis/dermatomyositis, Sjoegren's syndrome, Behcet disease, multiple sclerosis, autoimmune diabetes, chronic thyroiditis, psoriasis, primary athyreosis, pernicious anaemia, myasthenia gravis, ulcerative colitis, chronic active hepatitis, autoimmune hemolytic anemia and idiopathic thrombocytopenic purpura). |
---|---|
AbstractList | PROBLEM TO BE SOLVED: To provide an immunomodulating agent, a cell adhesion inhibitor and an agent for the treatment and prevention of autoimmune diseases except for rheumatoid arthritis. SOLUTION: A 4H-1-benzopyran-4-one derivative of formula or its salt has excellent immunomodulating action and cell adhesion inhibiting action and is expectable to have an ameliorating effect on the autoimmune diseases except for rheumatoid arthritis comparable to the effect of steroid drugs. Accordingly, the 4H-1-benzopyran-4-one derivative of formula or its salt is useful for the treatment and prevention of autoimmune diseases except for rheumatoid arthritis (such as systemic lupus erythematosus, scleroderma, mixed connective tissue disease, polyarteritis nodosa, multiple myositis/dermatomyositis, Sjoegren's syndrome, Behcet disease, multiple sclerosis, autoimmune diabetes, chronic thyroiditis, psoriasis, primary athyreosis, pernicious anaemia, myasthenia gravis, ulcerative colitis, chronic active hepatitis, autoimmune hemolytic anemia and idiopathic thrombocytopenic purpura). |
Author | SHIMOTORI TOMOYA TANIGUCHI YOICHI OSHIO ICHIRO INABA TAKIHIRO TAKANO SHUNTARO MAKINO SHINJI YOSHIDA CHOSAKU AIKAWA YUKIHIKO TANAKA KEIICHI |
Author_xml | – fullname: AIKAWA YUKIHIKO – fullname: YOSHIDA CHOSAKU – fullname: TANAKA KEIICHI – fullname: MAKINO SHINJI – fullname: OSHIO ICHIRO – fullname: TANIGUCHI YOICHI – fullname: INABA TAKIHIRO – fullname: TAKANO SHUNTARO – fullname: SHIMOTORI TOMOYA |
BookMark | eNqNjM0KgkAUhWdRi358h0vrAlOk9c256g1nRnRsKxLTSlSw9yetHqDV-eE7ZytW_dC7jehYqVobZWSdo2WdAqak7RFiynNAmVHFRgPrjK9sTQmo5ReBZE62JLRqSUtflHSf_TIwCWBtzeedQHJFWNFerJ9tNznvpztxSMjG2cmNQ-OmsX243r2aWxH4fniOoiC8YPgX9AbM9jjl |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
Edition | 7 |
ExternalDocumentID | JP2003155237A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_JP2003155237A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 12:08:43 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_JP2003155237A3 |
Notes | Application Number: JP20020274477 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030527&DB=EPODOC&CC=JP&NR=2003155237A |
ParticipantIDs | epo_espacenet_JP2003155237A |
PublicationCentury | 2000 |
PublicationDate | 20030527 |
PublicationDateYYYYMMDD | 2003-05-27 |
PublicationDate_xml | – month: 05 year: 2003 text: 20030527 day: 27 |
PublicationDecade | 2000 |
PublicationYear | 2003 |
RelatedCompanies | TOYAMA CHEM CO LTD |
RelatedCompanies_xml | – name: TOYAMA CHEM CO LTD |
Score | 2.5729795 |
Snippet | PROBLEM TO BE SOLVED: To provide an immunomodulating agent, a cell adhesion inhibitor and an agent for the treatment and prevention of autoimmune diseases... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | IMMUNOMODULATING AGENT, CELL ADHESION INHIBITOR AND AGENT FOR TREATMENT AND PREVENTION OF AUTOIMMUNE DISEASE |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030527&DB=EPODOC&locale=&CC=JP&NR=2003155237A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8gGvVNUYOipjFmTy4aNrbxQMxYOzbC1gUG4Y3APhKjGURm_Pe9VlCeeGv6cWkvvbtee_crwKORWHO06pZqpKml6rnWVBdtLVPnwjnI8NCv5yJ3OAgNb6z3p61pBd63uTASJ_RbgiOiRCUo76XU16v_SywqYyvXz4s3rFq-unGHKlvvGHdv01Rot8MiTrmjOE6nHynhULYJtDHNtA_gEM_RphAHNumKtJTVrk1xz-AoQnJFeQ6VrKjBibP9eq0Gx8HmxRuLG-FbX8CHHwTjkAecjgd27Ic9YvdYGD8Rhw0GxKYeE4qR-KHnd_2YD4kd0t8uBF09Eg-ZHQvoflmPnJ9gWQzgLsFdyiV1Rqg_YvaIXcKDy2LHU3Hasz8mzfrRzhK1K6gWyyKrA0H9kWoCNdRMLB3dl7bezs00NVpJrjfNxLyGxh5CN3tbG3AqY9teRFrbLVTLz6_sDm10ubiXvP0BXRiLiw |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEG8QjfimqFHxozFmTy4aNrbxQMxYOzbcugUK4Y3APhKjGURm_Pe9VlCeeGv6cWkvvbtee_crQg9GYs3AqluqkaaWqudaU523tUydCecgg0O_novc4ZAZ3kjvT1qTCnrf5MJInNBvCY4IEpWAvJdSXy__L7GIjK1cPc3foGrx4vIOUTbeMezepqmQbofGEYkcxXE6_VhhA9km0MY0095D-3DGNoU40HFXpKUst22Ke4wOYiBXlCeokhV1VHM2X6_V0WG4fvGG4lr4Vqfoww_DEYvCiIwCm_ush-0eZfwROzQIsE08KhQj9pnnd30eDbDNyG8XDK4e5gNqcwHdL-uB82MoiwGRi2GXRpI6xcQfUntIz9C9S7njqTDt6R-Tpv14a4naOaoWiyK7QBj0R6oJ1FAzsXRwX9p6OzfT1Gglud40E_MSNXYQutrZeodqHg-DaeCz1wY6knFuzyLF7RpVy8-v7AbsdTm_lXz-ARWrjn4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=IMMUNOMODULATING+AGENT%2C+CELL+ADHESION+INHIBITOR+AND+AGENT+FOR+TREATMENT+AND+PREVENTION+OF+AUTOIMMUNE+DISEASE&rft.inventor=AIKAWA+YUKIHIKO&rft.inventor=YOSHIDA+CHOSAKU&rft.inventor=TANAKA+KEIICHI&rft.inventor=MAKINO+SHINJI&rft.inventor=OSHIO+ICHIRO&rft.inventor=TANIGUCHI+YOICHI&rft.inventor=INABA+TAKIHIRO&rft.inventor=TAKANO+SHUNTARO&rft.inventor=SHIMOTORI+TOMOYA&rft.date=2003-05-27&rft.externalDBID=A&rft.externalDocID=JP2003155237A |